In a move that’s sending shockwaves through global markets, US President Donald Trump announced a 100% tariff on select patented pharmaceuticals and ingredients, citing national security concerns. The executive order, signed Thursday, takes effect July 31, 2026, and could reshape healthcare supply chains worldwide. 🚨
What’s Affected?
The tariffs target patented drugs and their components, but exemptions include generics, biosimilars, and critical therapies like gene treatments. Companies with US-approved "onshoring" plans get a temporary 20% rate until 2030—a clear push for domestic production. 🏭
Global Reactions
Allies face lower rates: Japan, the EU, and the Republic of Korea get 15%, while Britain sees 10%. Analysts warn this could strain trade ties and drive up drug prices globally. 💸 "This isn’t just about America—it’s a domino effect," said trade expert Mia Chen via Zoom.
Why It Matters
For young professionals and entrepreneurs: Watch pharma stocks and Asian manufacturing hubs. Students, track policy debates on TikTok—#DrugCosts is already trending. Travelers? Brace for potential medication shortages abroad. 🌏
